/ Not yet recruitingPhase 1 A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin 50/1000 mg Film-coated Tablets and Reference Product (GALVUS MET (50 MG/1000 MG)) in Healthy Thai Volunteers under Fed Conditions
Start Date06 Feb 2025 |
Sponsor / Collaborator- |
/ Not yet recruitingPhase 1 Start Date09 Jul 2024 |
Sponsor / Collaborator- |
/ CompletedNot Applicable Comparative bioequivalence study of the Sitagliptin 50 mg/ Metformin 1000 mg Tablets manufactured by Raha Pharmaceutical Company
Start Date05 Jul 2024 |
Sponsor / Collaborator- |
100 Clinical Results associated with DPP-4 x GPD1 x PRKAB1
100 Translational Medicine associated with DPP-4 x GPD1 x PRKAB1
0 Patents (Medical) associated with DPP-4 x GPD1 x PRKAB1